This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
The chemical structure of C1, a conjugate incorporating two active elements: Doxorubicin (Dox), a powerful cancer chemotherapy agent that's been used for decades; and a dichloroacetic acid (DCA) subunit, which reverses a cell's metabolism to anaerobic. University of Texas at Austin
A group of researchers have announced they have discovered a new drug combination that can overcome cancer drug resistance, as well as reduce the size of cancerous tumors to a far greater degree than current treatments.
The new approach can also be applied to any type of cancer, researchers from The University of Texas at Austin and Korea University said.
